Skip to main content

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. den Boer MEJ, Wanders RJA, Morris AAM, Ijlst L, Heymans HSA, Wijburg FA (2002) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics 109:99–104

    Google Scholar 

  2. Bonham JR, Tanner MS, Pollitt RJ, Manning NJ, Olpin SE, Downing M, Robertson L, Pourfarzam M, Bartlett K (1999) Oral sodium 3-hydroxybutyrate, a novel adjunct to treatment formultiple acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis (Suppl 1) 22:1001

    Google Scholar 

  3. Bonnet D, Martin D, de Lonlay P, Villain E, Jouvet P, Rabier D, Brivet M, Saudubray JM (1999) Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation 100:2248–2253

    CAS  PubMed  Google Scholar 

  4. Gillingham M, Van Calcar S, Ney D, Wolff J, Harding C (1999) Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD): a case report and survey. J Inherit Metab Dis 22:123–131

    Article  CAS  PubMed  Google Scholar 

  5. Lund AM, Dixon MA, Vreken P, Leonard JV, Morris AAM (2003a) What is the role of medium-chain triglycerides in the management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency? J Inherit Metab Dis 26:353–360

    CAS  PubMed  Google Scholar 

  6. Lund AM, Dixon MA, Vreken P, Leonard JV, Morris AAM (2003b) Plasma and erythrocyte fatty acid concentrations in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 26:410–412

    CAS  PubMed  Google Scholar 

  7. Morris AAM, Olpin SE, Brivet M, Turnbull DM, Jones RAK, Leonard JV (1998) A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype. J Pediatr 132:514–516

    CAS  PubMed  Google Scholar 

  8. Parini R, Invernizzi F, Menni F, Garavaglia B, Melotti D, Rimoldi M, Salera S, Tosetto C, Taroni F (1999) Medium-chain triglyceride loading test in carnitine-acylcarnitine transferase deficiency: insights on treatment. J Inherit Metab Dis 22:733–739

    Article  CAS  PubMed  Google Scholar 

  9. Roe CR, Sweetman L, Roe DS, David F, Brunengraber F (2002) Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Invest 110:259–269

    Article  CAS  PubMed  Google Scholar 

  10. Saudubray JM, Martin D, de Lonlay P, Touati G, Poggi-Travert F, Bonnet D, Jouvet P, Boutron M, Slama A, Vianey-Saban C, Bonnefont JP, Rabier D, Kamoun P, Brivet M (1999) Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 22:488–502

    Article  CAS  PubMed  Google Scholar 

  11. Shortland GJ, Schmidt M, Losty H, Leonard JV (2001) LCHAD deficiency treated with creatine. J Inherit Metab Dis (Suppl 1) 24:71

    Google Scholar 

  12. Sim KG, Hammond J, Wilcken B (2002) Strategies for the diagnosis of mitochondrial fatty acid β-oxidation defects. Clin Chim Acta 323:37–58

    Article  CAS  PubMed  Google Scholar 

  13. Solis JO, Singh RH (2002) Management of fatty acid oxidation disorders: A survey of current treatment strategies. J Am Diet Assoc 102:1800–1806

    Article  PubMed  Google Scholar 

  14. Tein I (1999) Neonatal myopathies. Sem Perinatol 23:125–151

    Article  CAS  Google Scholar 

  15. Tein I, Donner EJ, Hale DE, Murphy EG (1995) Clinical and neurophysiologic response of myopathy in long-chain l-3-hydroxyacyl-CoA dehydrogenase deficiency to oral prednisone. Pediatr Neurol 12:68–76

    CAS  PubMed  Google Scholar 

  16. Van Hove JLK, Grünewald S, Jaeken J, Demaerel P, Declercq PE, Bourdoux P (2003) D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD). Lancet 361:1433–1435

    PubMed  Google Scholar 

  17. Vockley J, Singh RH, Whiteman DAH (2002) Diagnosis and management of defects of mitochondrial β-oxidation. Curr Opin Clin Nutr Metab Care 5:601–609

    Article  CAS  PubMed  Google Scholar 

  18. Wanders RJA, Vreken P, den Boer MEJ, Wijburg AH, van Gennip AH, Ijlst L (1999) Disorders of mitochondrial fatty acyl-CoA β-oxidation. J Inherit Metab Dis 22:442–487

    CAS  PubMed  Google Scholar 

  19. Winter SC (2003) Treatment of carnitine deficiency. J Inherit Metab Dis 26:171–180

    Article  CAS  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

de Baulny, H.O., Superti-Furga, A. (2006). Disorders of Mitochondrial Fatty Acid Oxidation and Ketone Body Metabolism. In: Blau, N., Leonard, J., Hoffmann, G.F., Clarke, J.T.R. (eds) Physician’s Guide to the Treatment and Follow-Up of Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28962-3_16

Download citation

  • DOI: https://doi.org/10.1007/3-540-28962-3_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22954-4

  • Online ISBN: 978-3-540-28962-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics